Views & Analysis Embracing New Science for new growth There is a quiet force in the biopharmaceutical industry that could have notable implications.
Articles Healthcare disrupted: four emerging business models New technologies and new business models are transforming life science companies. A new book from Accenture maps out the fresh approaches being taken across healthcare.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
